ImmunityBio (IBRX) EBT Margin (2014 - 2026)
ImmunityBio (IBRX) reported EBT Margin of 1431.45% for Q1 2026, down 64499.0% year-over-year from N/an in Q1 2025, and down 782.6% quarter-over-quarter from 162.19% in Q4 2025.
ImmunityBio (IBRX) EBT Margin (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of EBT Margin data on file, last reported at 1431.45% in Q1 2026.
- EBT Margin for Q1 2026 came in at 1431.45%, down 64499.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 606.12% (up 70518.0% YoY), and the FY2025 annual result was 310.37%, up 249496.0% from the prior year.
- EBT Margin declined to 1431.45% in Q1 2026 per IBRX's latest filing, from 162.19% in the prior quarter.
- Over five years, EBT Margin peaked at 162.19% in Q4 2025 and troughed at 735700.0% in Q1 2022.
- A 5-year average of 132740.67% and a median of 32384.17% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2023: EBT Margin plunged 67780432 bps in 2022, then soared 70331583 bps in 2023.
- A 5-year view of EBT Margin shows it stood at 148345.21% in 2022, then dropped by 13 bps to 167952.52% in 2023, then soared by 100 bps to 783.62% in 2024, then soared by 79 bps to 162.19% in 2025, then sank by 783 bps to 1431.45% in 2026.
- Business Quant data shows IBRX's EBT Margin at 1431.45% in Q1 2026, 162.19% in Q4 2025, and 209.94% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | -1,431.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,431.45% |
| Dec 31, 2025 | -162.19% |
| Sep 30, 2025 | -209.94% |
| Jun 30, 2025 | -349.31% |
| Mar 31, 2025 | -786.46% |
| Dec 31, 2024 | -783.62% |
| Sep 30, 2024 | -1,404.39% |
| Jun 30, 2024 | -12,854.25% |
| Mar 31, 2024 | -335,325.00% |
| Dec 31, 2023 | -167,952.52% |
| Sep 30, 2023 | -116,636.59% |
| Jun 30, 2023 | -337,104.88% |
| Mar 31, 2023 | -32,384.17% |
| Dec 31, 2022 | -148,345.21% |
| Sep 30, 2022 | -94,204.24% |
| Jun 30, 2022 | -270,957.14% |
| Mar 31, 2022 | -735,700.00% |
| Dec 31, 2021 | -23,474.87% |
| Sep 30, 2021 | -133,983.33% |
| Jun 30, 2021 | -26,366.67% |